Want to see TSE:LOVE full AI Analyst Report?
Cannara Biotech (LOVE) Ratios
Cannara Biotech Ratios
TSE:LOVE's free cash flow for Q3 2026 was $805.11K. For the 2026 fiscal year, TSE:LOVE's free cash flow was decreased by $-4.40M and operating cash flow was $5.21M. See a summary of the company’s cash flow.
| Ratios | Aug 25 | Aug 24 | Nov 23 | Aug 22 | Nov 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.40 | 2.50 | 2.44 | 3.46 | 2.82 |
| Quick Ratio | 1.10 | 1.01 | 0.85 | 1.86 | 1.73 |
| Cash Ratio | 0.42 | 0.25 | 0.20 | 1.02 | 1.19 |
| Solvency Ratio | 0.30 | 0.19 | 0.19 | 0.11 | -0.00 |
| Operating Cash Flow Ratio | 0.59 | 0.40 | 0.26 | -0.51 | -0.31 |
| Short-Term Operating Cash Flow Coverage | 1.54 | 1.16 | 0.91 | -3.09 | -6.90 |
| Net Current Asset Value | $ 15.73M | $ 705.36K | $ -10.08M | $ -17.89M | $ -8.66M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.25 | 0.31 | 0.32 | 0.39 | 0.23 |
| Debt-to-Equity Ratio | 0.41 | 0.55 | 0.57 | 0.73 | 0.33 |
| Debt-to-Capital Ratio | 0.29 | 0.35 | 0.36 | 0.42 | 0.25 |
| Long-Term Debt-to-Capital Ratio | 0.22 | 0.30 | 0.33 | 0.41 | 0.24 |
| Financial Leverage Ratio | 1.65 | 1.76 | 1.77 | 1.88 | 1.44 |
| Debt Service Coverage Ratio | 1.35 | 1.15 | 1.40 | 1.91 | 0.82 |
| Interest Coverage Ratio | 5.10 | 1.78 | 2.24 | 1.11 | 0.11 |
| Debt to Market Cap | 0.25 | 0.78 | 0.51 | 0.41 | 0.16 |
| Interest Debt Per Share | 0.50 | 0.60 | 0.57 | 0.59 | 0.30 |
| Net Debt to EBITDA | 0.96 | 2.75 | 2.63 | 3.80 | 3.95 |
| Profitability Margins | |||||
| Gross Profit Margin | 44.00% | 36.44% | 47.56% | 48.36% | 60.50% |
| EBIT Margin | 20.29% | 10.78% | 18.91% | 12.49% | 0.22% |
| EBITDA Margin | 26.52% | 18.55% | 27.54% | 26.62% | 18.94% |
| Operating Profit Margin | 20.68% | 12.33% | 20.76% | 10.25% | 1.13% |
| Pretax Profit Margin | 16.86% | 5.49% | 12.13% | 6.43% | -8.98% |
| Net Profit Margin | 12.18% | 7.88% | 12.13% | 6.43% | -18.18% |
| Continuous Operations Profit Margin | 12.18% | 7.88% | 12.13% | 6.43% | -8.98% |
| Net Income Per EBT | 72.26% | 143.59% | 100.00% | 100.00% | 202.49% |
| EBT Per EBIT | 81.53% | 44.49% | 58.42% | 62.78% | -793.44% |
| Return on Assets (ROA) | 7.75% | 4.16% | 4.91% | 1.84% | -3.36% |
| Return on Equity (ROE) | 12.79% | 7.32% | 8.71% | 3.45% | -4.83% |
| Return on Capital Employed (ROCE) | 16.51% | 7.89% | 9.88% | 3.23% | 0.23% |
| Return on Invested Capital (ROIC) | 10.86% | 7.34% | 9.41% | 3.17% | 0.22% |
| Return on Tangible Assets | 7.75% | 4.16% | 4.91% | 1.84% | -3.36% |
| Earnings Yield | 7.86% | 10.51% | 7.78% | 1.95% | -2.38% |
| Efficiency Ratios | |||||
| Receivables Turnover | 7.61 | 6.27 | 5.41 | 4.16 | 5.73 |
| Payables Turnover | 5.42 | 26.45 | 3.38 | 2.17 | 1.09 |
| Inventory Turnover | 1.35 | 1.30 | 0.89 | 0.98 | 0.91 |
| Fixed Asset Turnover | 1.25 | 0.96 | 0.64 | 0.43 | 0.24 |
| Asset Turnover | 0.64 | 0.53 | 0.40 | 0.29 | 0.18 |
| Working Capital Turnover Ratio | 2.43 | 2.30 | 1.92 | 1.73 | 1.75 |
| Cash Conversion Cycle | 251.03 | 325.90 | 370.01 | 293.73 | 129.82 |
| Days of Sales Outstanding | 47.98 | 58.21 | 67.52 | 87.76 | 63.65 |
| Days of Inventory Outstanding | 270.36 | 281.49 | 410.49 | 374.25 | 402.27 |
| Days of Payables Outstanding | 67.31 | 13.80 | 108.00 | 168.28 | 336.10 |
| Operating Cycle | 318.33 | 339.70 | 478.01 | 462.01 | 465.92 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.22 | 0.12 | 0.06 | -0.07 | -0.03 |
| Free Cash Flow Per Share | 0.15 | 0.04 | -0.05 | -0.25 | -0.43 |
| Dividend Paid and CapEx Coverage Ratio | 3.15 | 1.43 | 0.55 | -0.39 | -0.07 |
| Capital Expenditure Coverage Ratio | 3.15 | 1.43 | 0.55 | -0.39 | -0.07 |
| Operating Cash Flow Coverage Ratio | 0.48 | 0.22 | 0.12 | -0.13 | -0.10 |
| Operating Cash Flow to Sales Ratio | 0.19 | 0.13 | 0.09 | -0.17 | -0.12 |
| Free Cash Flow Yield | 8.21% | 5.25% | -4.97% | -18.20% | -25.50% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 12.86 | 9.51 | 12.86 | 51.34 | -42.04 |
| Price-to-Sales (P/S) Ratio | 1.55 | 0.75 | 1.56 | 3.30 | 7.64 |
| Price-to-Book (P/B) Ratio | 1.63 | 0.70 | 1.12 | 1.77 | 2.03 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 12.18 | 19.06 | -20.10 | -5.49 | -3.92 |
| Price-to-Operating Cash Flow Ratio | 8.31 | 5.73 | 16.42 | -19.47 | -62.15 |
| Price-to-Earnings Growth (PEG) Ratio | 0.13 | -1.17 | 0.07 | -0.31 | 0.53 |
| Enterprise Value Multiple | 6.80 | 6.79 | 8.29 | 16.21 | 44.30 |
| Enterprise Value | 193.48M | 102.95M | 130.81M | 154.63M | 142.81M |
| EV to EBITDA | 6.80 | 6.79 | 8.29 | 16.21 | 44.30 |
| EV to Sales | 1.80 | 1.26 | 2.28 | 4.31 | 8.39 |
| EV to Free Cash Flow | 14.17 | 32.03 | -29.45 | -7.18 | -4.31 |
| EV to Operating Cash Flow | 9.67 | 9.64 | 24.06 | -25.44 | -68.24 |
| Tangible Book Value Per Share | 1.11 | 0.98 | 0.89 | 0.76 | 0.84 |
| Shareholders’ Equity Per Share | 1.11 | 0.98 | 0.89 | 0.76 | 0.84 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.28 | -0.44 | 0.00 | -0.24 | -1.02 |
| Revenue Per Share | 1.16 | 0.91 | 0.64 | 0.41 | 0.22 |
| Net Income Per Share | 0.14 | 0.07 | 0.08 | 0.03 | -0.04 |
| Tax Burden | 0.72 | 1.44 | 1.00 | 1.00 | 2.02 |
| Interest Burden | 0.83 | 0.51 | 0.64 | 0.51 | -40.15 |
| Research & Development to Revenue | 0.01 | 0.01 | 0.02 | 0.04 | 0.11 |
| SG&A to Revenue | 0.22 | 0.16 | 0.19 | 0.24 | 0.36 |
| Stock-Based Compensation to Revenue | 0.01 | 0.02 | 0.03 | 0.01 | 0.02 |
| Income Quality | 1.53 | 1.66 | 0.78 | -2.64 | 1.37 |
Currency in CAD
